Myung-Gyu Kim
Overview
Explore the profile of Myung-Gyu Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
775
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Choi Y, Kim S, Ryu D, Park S, Koo T, et al.
Kidney Res Clin Pract
. 2025 Feb;
PMID: 39980095
Background: Membranoproliferative glomerulonephritis (MPGN) has two subtypes based on immunofluorescence findings: complement 3 glomerulopathy (C3G) and immune complex-mediated MPGN (IC-MPGN). This study investigated the characteristics and prognosis of patients with...
2.
3.
Kim H, Kim K, Joo Y, Ryu J, Jung H, Jeong K, et al.
Transpl Int
. 2024 Aug;
37:12574.
PMID: 39170864
The optimal target blood pressure for kidney transplant (KT) patients remains unclear. We included 808 KT patients from the KNOW-KT as a discovery set, and 1,294 KT patients from the...
4.
Ha J, Jeong J, Ryu J, Kim M, Huh K, Lee K, et al.
Kidney Dis (Basel)
. 2024 Aug;
10(4):249-261.
PMID: 39131884
Introduction: Coronary artery calcification score (CACS) and abdominal aortic calcification score (AACS) are both well-established markers of vascular stiffness, and previous studies have shown that a higher CACS is a...
5.
Lee J, Cho D, Min H, Son Y, Kim T, Oh S, et al.
BMC Pulm Med
. 2024 Feb;
24(1):78.
PMID: 38341544
Background: Pulmonary hypertension (PH) is a complication of chronic kidney disease (CKD) that contributes to mortality. Sclerostin, a SOST gene product that reduces osteoblastic bone formation by inhibiting Wnt/β-catenin signaling,...
6.
Jeon H, Ryu J, Kim M, Huh K, Lee K, Kim C, et al.
Transplantation
. 2024 Jan;
108(5):1239-1248.
PMID: 38291579
Background: Vascular calcification and stiffness contribute to increased cardiovascular morbidity in patients with chronic kidney disease. This study investigated associations between serum osteoprotegerin (OPG) levels and vascular calcification or stiffness...
7.
Yim S, Kim H, Ro H, Ryu J, Kim M, Park J, et al.
Sci Rep
. 2024 Jan;
14(1):2002.
PMID: 38263253
Cardiovascular disease remains a leading cause of morbidity and mortality after kidney transplantation (KT). Although statins reduce cardiovascular risk and have renal benefits in the general population, their effects on...
8.
Kim T, Ahn S, Oh J, Bae E, Chin H, Kim M, et al.
J Korean Med Sci
. 2024 Jan;
39(3):e12.
PMID: 38258359
Background: The obesity epidemic is associated with the emergence of new kidney diseases including obesity-related glomerulopathy (ORG) and metabolic syndrome-associated disorders. However, the effects of obesity on prevalence and outcome...
9.
Jung H, Ryu J, Kim M, Huh K, Lee K, Jung H, et al.
Am J Nephrol
. 2024 Jan;
55(2):245-254.
PMID: 38198780
Introduction: Serum activin A has been reported to contribute to vascular calcification and kidney fibrosis in chronic kidney disease. We aimed to investigate whether higher serum activin levels were associated...
10.
Kim M, Cho W, Chung S, Choi Y, Fang Y, Park M, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1238960.
PMID: 38020091
Introduction: This study investigated the role of renal-intestinal crosstalk in the transition from acute kidney injury (AKI) to chronic kidney disease (CKD) in elderly individuals. Methods: Using young and aged...